In the latest session, Select Medical Holdings Corporation (NYSE: SEM) closed at $28.23 down -1.71% from its previous closing price of $28.72. In other words, the price has decreased by -$0.49 from its previous closing price. On the day, 584558 shares were traded.
Ratios:
For a deeper understanding of Select Medical Holdings Corporation’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 43.13 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.27. For the most recent quarter (mrq), Quick Ratio is recorded 1.01 and its Current Ratio is at 1.01. In the meantime, Its Debt-to-Equity ratio is 3.85 whereas as Long-Term Debt/Eq ratio is at 3.58.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, The Benchmark Company on May 13, 2021, Reiterated its Buy rating but revised its target price to $44 from $40 previously.
On February 26, 2021, BofA Securities Upgraded its rating to Buy which previously was Underperform and also upped its target price recommendation from $30 to $36.
BofA/Merrill Downgraded its Neutral to Underperform on June 16, 2020, whereas the target price for the stock was revised from $18 to $15.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 08 ’24 when ORTENZIO ROBERT A sold 50,000 shares for $29.90 per share. The transaction valued at 1,495,000 led to the insider holds 6,689,668 shares of the business.
ORTENZIO ROBERT A sold 50,000 shares of SEM for $1,415,000 on Mar 08 ’24. The EXECUTIVE CHAIRMAN now owns 6,739,668 shares after completing the transaction at $28.30 per share. On Feb 08 ’24, another insider, ORTENZIO ROBERT A, who serves as the EXECUTIVE CHAIRMAN of the company, sold 50,000 shares for $26.00 each. As a result, the insider received 1,300,000 and left with 6,789,668 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SEM now has a Market Capitalization of 3.62B and an Enterprise Value of 8.44B. As of this moment, Select’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.79, and their Forward P/E ratio for the next fiscal year is 13.20. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.46. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.54 while its Price-to-Book (P/B) ratio in mrq is 2.81. Its current Enterprise Value per Revenue stands at 1.27 whereas that against EBITDA is 10.69.
Stock Price History:
Over the past 52 weeks, SEM has reached a high of $33.51, while it has fallen to a 52-week low of $21.28. The 50-Day Moving Average of the stock is 27.96, while the 200-Day Moving Average is calculated to be 26.65.
Shares Statistics:
For the past three months, SEM has traded an average of 495.83K shares per day and 528.43k over the past ten days. A total of 128.37M shares are outstanding, with a floating share count of 100.27M. Insiders hold about 21.88% of the company’s shares, while institutions hold 77.32% stake in the company. Shares short for SEM as of Mar 15, 2024 were 2.52M with a Short Ratio of 4.48, compared to 2.78M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.96% and a Short% of Float of 3.82%.
Dividends & Splits
According to the company, the forward annual dividend rate for SEM is 0.50, from 0.50 in the trailing year. Against a Trailing Annual Dividend Yield of 1.74%, it implies a Forward Annual Dividend Yield of 1.70%.
Earnings Estimates
There are 4 different market analysts currently analyzing its stock. On average, analysts expect EPS of $0.57 for the current quarter, with a high estimate of $0.58 and a low estimate of $0.57, while EPS last year was $0.56. The consensus estimate for the next quarter is $0.64, with high estimates of $0.65 and low estimates of $0.64.
Analysts are recommending an EPS of between $2.06 and $2.02 for the fiscal current year, implying an average EPS of $2.03. EPS for the following year is $2.09, with 4 analysts recommending between $2.2 and $1.93.
Revenue Estimates
A total of 5 analysts believe the company’s revenue will be $1.74B this quarter.It ranges from a high estimate of $1.76B to a low estimate of $1.7B. As of the current estimate, Select Medical Holdings Corporation’s year-ago sales were $1.66B, an estimated increase of 4.40% from the year-ago figure. For the next quarter, 5 analysts are estimating revenue of $1.75B, an increase of 4.60% over than the figure of $4.40% in the same quarter last year. There is a high estimate of $1.76B for the next quarter, whereas the lowest estimate is $1.74B.
A total of 5 analysts have provided revenue estimates for SEM’s current fiscal year. The highest revenue estimate was $7B, while the lowest revenue estimate was $6.9B, resulting in an average revenue estimate of $6.97B. In the same quarter a year ago, actual revenue was $6.66B, up 4.60% from the average estimate. Based on 5 analysts’ estimates, the company’s revenue will be $7.29B in the next fiscal year. The high estimate is $7.34B and the low estimate is $7.25B. The average revenue growth estimate for next year is up 4.60% from the average revenue estimate for this year.
